The rising popularity of these drugs has changed people’s baseline perceptions of them, which in turn can raise expectations going into a trial. A psychedelic trip can be a challenging, even harrowing, experience, often with therapeutically positive outcomes – but sometimes with negative ones. That shouldn’t put the brakes on psychedelic research. But it does…
…the increasing interest that mainstream biotech firms are developing for psychedelic compounds. While about 100 clinical trials focused on psychedelic compounds are chugging along in the regulatory pathway to examine the potential the drugs have to treat illnesses like depression and alcoholism, Big Pharma has largely taken a back seat in the growing industry, holding…
…research points to a need to look at steps to reduce alcohol consumption, including increasing alcohol taxes and enacting measures that limit where people can buy beer, wine and liquor. The study found that as many as 1 in 8 deaths among U.S. adults ages 20 to 64 were alcohol-related deaths… 52,000 such deaths last…
…the research team recruited 641 participants… published in Drug Science, Policy, and Law… …the results of these efforts found that those with a history of psilocybin, followed by LSD, scored highest in “nature relatedness” and knowledge of climate change… has made new inroads into understanding the relationship between taking psychedelics and feeling connected to nature… Original…
…when asked whether they would support legalization of some or all psychedelics for other purposes, 28 percent were in favor of legalization for religious or spiritual purposes, while 26 percent were in favor of recreational legalization. One survey carried out in August 2022 among 181 U.S. psychiatrists found many took issue with the federal classification of some…
Compass… phase 2B data, which has yet to be formally published in a peer-reviewed journal… with five patients (6.3%) in the 25-mg group and six patients (8%) in the 10-mg group experiencing serious adverse events during the follow-up period…. These adverse events included suicidal ideation and suicidal behavior. The first Phase 3 trial has been…
…because there’s a dimension of mind changing with psychedelics, it takes off all the fences and we are more open to think differently, or to take another path. I will go back to the example of the elephants who travel another path. This is something that you can see in MRIs. There are new connections…
In 2021 study it was recognised that high moisture and moderate temperatures are the ideal settings for mushroom growth, suggesting that droughts dry the soil, meaning that less plants and fungi have an opportunity to survive. Water transportation is pivotal to mycelium growth, and it is widely accepted that an increase in drought affects interactions…
…researchers have built a virtual library of 75 million compounds related to these drugs. This approach yielded two molecules that showed antidepressant properties in mice, but without the hallucinogenic activity of psychedelic drugs. Original Article (Nature):Virtual library of LSD-like drugs could reveal new antidepressantsArtwork Fair Use: Jimmy-neutron
When controlling for confounding variables, the results revealed that lifetime psychedelic use was not associated with lifetime cancer diagnosis nor hematologic cancer diagnosis. This was true for each of the three classifications of psychedelics: tryptamine (5-MeO-DIPT, AMT, DMT), lysergamide (LSD), and phenethylamine (2C-B, mescaline, MDMA, peyote, and San Pedro). “Beginning in the late 1960s, concerns were raised by laboratory experiments that…
Recent Comments